These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7374272)

  • 21. Aspirin for prevention of myocardial infarction. A double-edged sword.
    Bar-Dayan Y; Levy Y; Amital H; Shoenfeld Y
    Ann Med Interne (Paris); 1997; 148(6):430-3. PubMed ID: 9538376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aspirin and prevention of myocardial infarction.
    Hartney TJ
    Biomed Pharmacother; 1989; 43(2):73-7. PubMed ID: 2660918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized comparative trial of triflusal and aspirin following acute myocardial infarction.
    Cruz-Fernández JM; López-Bescós L; García-Dorado D; López García-Aranda V; Cabadés A; Martín-Jadraque L; Velasco JA; Castro-Beiras A; Torres F; Marfil F; Navarro E
    Eur Heart J; 2000 Mar; 21(6):457-65. PubMed ID: 10681486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The aspirin myocardial infarction study: final results. The Aspirin Myocardial Infarction Study research group.
    Circulation; 1980 Dec; 62(6 Pt 2):V79-84. PubMed ID: 7438383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of gender on prevention of myocardial infarction by antihypertensives and acetylsalicylic acid: the HOT study.
    Kjeldsen SE; Warnold I; Hansson L;
    J Gend Specif Med; 2000; 3(8):35-8. PubMed ID: 11253266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of myocardial infarction from the patient.
    Rodgers KA
    N Z Med J; 1994 Apr; 107(975):140-1. PubMed ID: 7908426
    [No Abstract]   [Full Text] [Related]  

  • 27. [The rate of acetylsalicylic acid non-respondents among patients hospitalized for acute coronary disease, previously undergoing secondary salicylic acid prophylaxis].
    Tarján J; Salamon A; Jáger R; Poór F; Barczi V; Dinnyés J; Hamvas J; Kinczel A; Pál A; Blaskó G
    Orv Hetil; 1999 Oct; 140(42):2339-43. PubMed ID: 10560261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction: results of the GISSI-3 Trial.
    Latini R; Santoro E; Masson S; Tavazzi L; Maggioni AP; Franzosi MG; Barlera S; Calvillo L; Salio M; Staszewsky L; Labarta V; Tognoni G;
    Heart Dis; 2000; 2(3):185-90. PubMed ID: 11728260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preventing death after myocardial infarction.
    Horwitz DL
    Compr Ther; 1980 Jun; 6(6):3-4. PubMed ID: 7379491
    [No Abstract]   [Full Text] [Related]  

  • 30. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
    Second Chinese Cardiac Study (CCS-2) Collaborative Group
    J Cardiovasc Risk; 2000 Dec; 7(6):435-41. PubMed ID: 11189013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trial of acetylsalicylic acid in the secondary prevention of mortality from myocardial infarction.
    Elwood P
    Br Med J (Clin Res Ed); 1981 Feb; 282(6262):481. PubMed ID: 6780093
    [No Abstract]   [Full Text] [Related]  

  • 32. [Can patients without coronary heart disease prevent a heart infarct with 30 or 50 mg acetylsalicylic acid?].
    Schreiber M; Sechtem U
    Dtsch Med Wochenschr; 2003 Dec; 128(50):2668. PubMed ID: 14673749
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of aspirin and ibuprofen compared with aspirin alone and the risk of myocardial infarction.
    Patel TN; Goldberg KC
    Arch Intern Med; 2004 Apr; 164(8):852-6. PubMed ID: 15111370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [What are the recommendations for acute therapy of myocardial infarct with acetylsalicylic acid and heparin, which analgesics should be prescribed?].
    Internist (Berl); 1995 Jun; 36(6):617. PubMed ID: 7665333
    [No Abstract]   [Full Text] [Related]  

  • 35. Some issues concerning treatment in patients after myocardial infarction.
    Poole-Wilson PA
    Arch Mal Coeur Vaiss; 1995 Aug; 88 Spec No 3():9-11. PubMed ID: 7503619
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs.
    Gottenberg JE; Sordet C; Sibilia J
    Circulation; 2004 Mar; 109(9):e157; author reply e157. PubMed ID: 15007025
    [No Abstract]   [Full Text] [Related]  

  • 37. Failure of aspirin to prevent myocardial infarction and adverse outcome during follow-up - a large series of all-comers.
    Mikkelsson J; Eskola M; Nikus K; Karhunen PJ; Niemela K
    Ann Med; 2008; 40(4):296-302. PubMed ID: 18428022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Characteristics of patients with coronary disease and aspirin prescription in Haute-Garonne].
    Cambou JP; Lablache-Combier B; Marques-Vidal P; Ruidavets JB; Branchu MP; Ferrières J
    Ann Cardiol Angeiol (Paris); 1994 Dec; 43(10):588-93. PubMed ID: 7864551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Hypertension Optimal Treatment study and the importance of lowering blood pressure.
    Hansson L
    J Hypertens Suppl; 1999 Feb; 17(1):S9-13. PubMed ID: 10340838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aspirin after myocardial infarction: the importance of over-the-counter use.
    Hopper S; Pierce M
    Fam Pract; 1998 Apr; 15 Suppl 1():S10-3. PubMed ID: 9613460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.